Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-10 10:49 am Sale |
2024-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
WELLINGTON MANAGEMENT CO LLP | 11,833,409 9.500% |
-3,766,120 (-24.14%) |
Filing History |
| 2025-02-03 1:09 pm Purchase |
2024-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
MORGAN STANLEY MS |
9,592,751 7.700% |
9,592,751 (New Position) |
Filing History |
| 2024-11-22 4:16 pm Sale |
2024-11-20 | 13G | Apellis Pharmaceuticals, Inc. APLS |
Deep Track Capital, LP | 6,000,000 4.820% |
-220,265 (-3.54%) |
Filing History |
| 2024-11-22 08:47 am Purchase |
2024-11-15 | 13G | Apellis Pharmaceuticals, Inc. APLS |
Deep Track Capital, LP | 6,220,265 5.000% |
6,220,265 (New Position) |
Filing History |
| 2024-11-14 1:28 pm Sale |
2024-09-30 | 13G | Apellis Pharmaceuticals, Inc. APLS |
T. Rowe Price Investment Management, Inc. | 2,985,272 2.500% |
-3,318,312 (-52.64%) |
Filing History |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Apellis Pharmaceuticals, Inc. APLS |
BLACKROCK INC BLK |
6,191,937 5.100% |
0 (Unchanged) |
Filing History |
| 2024-11-08 10:52 am Sale |
2024-09-30 | 13G | Apellis Pharmaceuticals, Inc. APLS |
WELLINGTON MANAGEMENT CO LLP | 15,599,529 12.810% |
-878,321 (-5.33%) |
Filing History |
| 2024-10-18 3:31 pm Purchase |
2024-09-30 | 13G | Apellis Pharmaceuticals, Inc. APLS |
BLACKROCK INC BLK |
6,191,937 5.100% |
444,753 (+7.74%) |
Filing History |
| 2024-02-14 5:18 pm Purchase |
2023-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
EcoR1 Capital LLC | 11,173,068 9.400% |
4,865,521 (+77.14%) |
Filing History |
| 2024-02-14 10:04 am Purchase |
2023-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
T. Rowe Price Investment Management, Inc. | 6,303,584 5.300% |
460,924 (+7.89%) |
Filing History |
| 2024-02-14 09:23 am Purchase |
2023-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
AVORO CAPITAL ADVISORS LLC | 13,411,111 9.900% |
2,786,111 (+26.22%) |
Filing History |
| 2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | Apellis Pharmaceuticals, Inc. APLS |
The Vanguard Group | 9,555,678 8.060% |
343,187 (+3.73%) |
Filing History |
| 2024-02-08 10:05 am Purchase |
2023-12-29 | 13G | Apellis Pharmaceuticals, Inc. APLS |
WELLINGTON MANAGEMENT CO LLP | 16,477,850 13.910% |
1,706,991 (+11.56%) |
Filing History |
| 2023-09-08 10:29 am Purchase |
2023-08-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
WELLINGTON MANAGEMENT CO LLP | 14,770,859 12.550% |
5,950,461 (+67.46%) |
Filing History |
| 2023-07-18 5:16 pm Purchase |
2023-07-18 | 13G | Apellis Pharmaceuticals, Inc. APLS |
EcoR1 Capital LLC | 6,307,547 5.400% |
6,307,547 (New Position) |
Filing History |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Apellis Pharmaceuticals, Inc. APLS |
BLACKROCK INC BLK |
5,747,184 4.900% |
-1,957,010 (-25.40%) |
Filing History |
| 2023-02-14 12:40 pm Purchase |
2022-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
T. Rowe Price Investment Management, Inc. | 5,842,660 5.300% |
5,842,660 (New Position) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
PRICE T ROWE ASSOCIATES INC | 2,749,542 2.500% |
-2,557,944 (-48.20%) |
Filing History |
| 2023-02-14 09:36 am Purchase |
2022-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
AVORO CAPITAL ADVISORS LLC | 10,625,000 9.600% |
2,069,445 (+24.19%) |
Filing History |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Apellis Pharmaceuticals, Inc. APLS |
The Vanguard Group | 9,212,491 8.330% |
1,295,392 (+16.36%) |
Filing History |